Could statins prevent age-related macular degeneration?

Bibliography

• JICK H, ZORNBERG GL, JICK SS, SESHADRI S, DRACHMAN DA: Statins and the risk of dementia. Lancet (2000) 356:1627–1631.
   PubMed Web of Science ®Google Scholar
• WOLOZIN B, KELLMAN W, RUOSSEAU P, CELESIA GG, SIEGEL G:Decreased prevalence of Alzheimer's disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neural. (2000) 57:1439–1443.
   PubMed Web of Science ®Google Scholar
• BYINGTON RP, DAVIS BR, PLEHN JFet al.: Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) project. Circulation (2001) 103:387–392.
   Google Scholar
• HALL NF, GALE CR, SYDDALL H, PHILLIPS DI, MARTYN CN: Risk of macular degeneration in users of statins: cross sectional study. Br. Med.' (2001) 323:375–376.
   PubMed Web of Science ®Google Scholar
• MCCARTY CA, MUKESH BN, GUYMER RH, BAIRD PN, TAYLOR HR: Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med. J. Aust. (2001) 175:340.
   PubMed Web of Science ®Google Scholar
• KLEIN R, KLEIN BE, LINTON KL: Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1992) 99:933–943.
   PubMed Web of Science ®Google Scholar
• KLEIN R, KLEIN BE, JENSEN SC, MEUER SM: The five-year incidence and progression of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1997) 104:7–21.
   PubMed Web of Science ®Google Scholar
• VINGERLING JR, DIELEMANS I, BOTS ML, HOFMAN A, GROBBEE DE, DE JONG PT: Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am. Epidemiol (1995) 142:404–409.
   PubMed Web of Science ®Google Scholar
• GREGOR Z, BIRD AC, CHISHOLM IH: Senile disciform macular degeneration in the second eye. Br. Ophthalmol (1977) 61:141–147.
   PubMed Web of Science ®Google Scholar
• FRIEDMAN E: The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am. J. Ophthalmol (2000) 130:658–663.
   PubMed Web of Science ®Google Scholar
• DELLA V, SCOROLLI L, MEDURI R: Retinal effects of simvastatin in patients affected by age related macular degeneration. Annali di Ottalmologia e Clinica Oculistica (2000) 126:89–95.
   Google Scholar
• MARES-PERLMAN JA, BRADY WE, KLEIN R, VANDENLANGENBERG GM, KLEIN BE, PALTA M: Dietary fat and age-related maculopathy. Arch. Ophthalmol (1995) 113:743–748.
   PubMed Web of Science ®Google Scholar
• KLEIN R, KLEIN BE, JENSEN SC: The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (1997) 104: 1804-1812.
   Google Scholar
• CHAINE G, HULLO A, SAHEL J et al: Case-control study of the risk factors for age related macular degeneration. Br. J. Ophthalmol (1998) 82:996–1002.
   PubMed Web of Science ®Google Scholar
• KLAVER CC, KLIFFEN M, VAN DUIJN CM et al: Genetic association of apolipoprotein E with age-related macular degeneration. Am. J. Hum. Genet. (1998) 63:200–206.
   PubMed Web of Science ®Google Scholar
• KUREISHI Y, LUO Z, SHIOJIMA I et al: The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat. Medicine (2000) 6:1004–1010.
   PubMed Web of Science ®Google Scholar
• SIMONS M: Molecular multitasking: statins lead to more arteries, less plaque. Nat. Medicine (2000) 6:965–956.
   PubMedGoogle Scholar
• BEATTY S, KOH H, PHIL M, HENS ON D, BOULTON M: The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol (2000) 45:115–134.
   PubMed Web of Science ®Google Scholar
• A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C, and E, beta carotene,, and zinc for age-related macular degeneration and vision loss. AREDS report No. 8. Arch. Ophthalmol (2002) 119:1417–1436.
   Google Scholar
• MARSHALL J: The ageing retina: physiology or pathology. Eye (1987) 1:282–295.
   PubMed Web of Science ®Google Scholar
• CHRISTEN WG, GLYNN RJ, MANSON JE, AJANI UA, BURING JE: A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA (1996) 276:1147–1451.
   PubMed Web of Science ®Google Scholar
• PENFOLD PL, KILLINGSWORTH MC, SARKS SH: Senile macular degeneration: the involvement of immunocompetent cells. Ginefes Arch. Clin. Exp. Ophthalmol (1985) 223:69–76.
   PubMed Web of Science ®Google Scholar
• LOPEZ PF, GROSSNIKLAUS HE, LAMBERT HM et al.: Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am. J. Ophthalmol (1991) 112:647–656.
   PubMed Web of Science ®Google Scholar
• KILLINGS WORTH MC, SARKS JP, SARKS SH: Macrophages related to Bruch's membrane in age-related macular degeneration. Eye (1990) 4:613–621.
   PubMedGoogle Scholar
• VAN DER SCHAFT TL, MOOY CM, DE BRUIJN WC, DE JONG PT: Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. ELI Ophthalmol (1993) 77:657–661.
   Google Scholar
• OH H, TAKAGI H,TAKAGI C et al: The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest. Ophthalmol Vis. Sci. (1999) 40:1891–1898.
   PubMed Web of Science ®Google Scholar
• ALBERT MA, DANIELSON E, RIFAI N, RIDKER PM, PRINCE I: Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA (2001) 286:64–70.
   PubMed Web of Science ®Google Scholar
• BLAKE GJ, RIDKER PM: Novel clinical markers of vascular wall inflammation. Circ. Res. (2001) 89:763–771.
   PubMed Web of Science ®Google Scholar
• MIYAGAWA N, OKAMOTO Y, NAKANO H: Effect of C-reactive protein on peritoneal macrophages. II. Human C-reactive protein activates peritoneal macrophages of guinea pigs to release superoxide anion M vitro. Microbial. Immunol (1988) 32:721–731.
   Google Scholar